Clinical Trials in Walla Walla, United States
Locations / Walla Walla, United States
Delta Trials catalogs 59 clinical trials conducted in Walla Walla, United States, making it a notable site of clinical research activity. These trials spanning 524 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Walla Walla evolve over time.
59
Total Trials
524
Conditions
1
Terminated since 2020
Browse by condition (524 total)
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- All Recurrent primary peritoneal carcinoma trials
- Ovarian seromucinous carcinoma 3 trialsAll Ovarian seromucinous carcinoma trials
- Stage iii anal cancer ajcc v8 2 trialsAll Stage iii anal cancer ajcc v8 trials
- Recurrent endometrial carcinoma 2 trialsAll Recurrent endometrial carcinoma trials
- All Minimally invasive lung adenocarcinoma trials
- Lung adenocarcinoma 2 trialsAll Lung adenocarcinoma trials